Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AB-101 |
Trade Name | |
Synonyms | AB101|AB 101 |
Drug Descriptions |
AB-101 are umbilical cord blood-derived NK cells expressing a high-affinity CD16 variant, which may lead to antibody-dependent cellular cytotoxicity and increased anti-tumor immune response (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C177152 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AB-101 | AB-101 | 0 | 0 |
AB-101 + AFM13 | AB-101 AFM13 | 0 | 1 |
AB-101 + Bendamustine + Rituximab | AB-101 Bendamustine Rituximab | 0 | 1 |
AB-101 + Rituximab | AB-101 Rituximab | 0 | 1 |